Last Updated on June 22, 2023

Therapeutic Advances in Hematology- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: SAGE Publications Inc.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

2.80

SJR

 1.011

h-Index

 32

Rank

 4148

Important Details

Title Therapeutic Advances in Hematology
Type of Publication Journal
Discipline Hematology (Q2)
Impact Score 2.80
SCImago Journal Rank (SJR) 1.011
h-index 32
Overall Rank 4148
Publisher Name SAGE Publications Inc.
Publication Country United States
International Standard Serial Number (ISSN) 20406207, 20406215
Coverage and History 2010-2017, 2019-2022
Best Quartile Q2
Total Citations Received
(Last 3 Year)
301

About Therapeutic Advances in Hematology


Therapeutic Advances in Hematology is a journal published by SAGE Publications Inc.. This journal covers the area[s] related to Hematology, etc. The coverage history of this journal is as follows: 2010-2017, 2019-2022. The rank of this journal is 4148. This journal's impact score, h-index, and SJR are 2.80, 32, and 1.011, respectively. The ISSN of this journal is/are as follows: 20406207, 20406215.

The best quartile of Therapeutic Advances in Hematology is Q2. This journal has received a total of 301 citations during the last three years (Preceding 2022).


Therapeutic Advances in Hematology Impact Score 2022-2023


The latest impact score (IS) of the Therapeutic Advances in Hematology is 2.80. It is computed in the year 2023 as per its definition and based on Scopus data. 2.80

It is decreased by a factor of around 2.75, and the percentage change is -49.55% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Therapeutic Advances in Hematology Impact Score 2023


Impact Score 2022 of Therapeutic Advances in Hematology is 2.80. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Therapeutic Advances in Hematology. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.80
2021 5.55
2020 6.56
2019 0.00
2018 2.67
2016 3.73
2015 3.42
2014 2.55

Therapeutic Advances in Hematology h-index


  Table Setting

The h-index of Therapeutic Advances in Hematology is 32. By definition of the h-index, this journal has at least 32 published articles with more than 32 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Therapeutic Advances in Hematology ISSN


The International Standard Serial Number (ISSN) of Therapeutic Advances in Hematology is/are as follows: 20406207, 20406215.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Therapeutic Advances in Hematology Ranking and SCImago Journal Rank (SJR)


The Therapeutic Advances in Hematology is ranked 4148 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 1.011.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Therapeutic Advances in Hematology Publisher


Table Setting

The publisher of Therapeutic Advances in Hematology is SAGE Publications Inc.. The publishing house of this journal is located in the United States. Its coverage history is as follows: 2010-2017, 2019-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


How to publish in Therapeutic Advances in Hematology


If your area of research or discipline is related to Hematology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Therapeutic Advances in Hematology?

The latest impact score of Therapeutic Advances in Hematology is 2.80. It is computed in the year 2023.


What is the h-index of Therapeutic Advances in Hematology?

The latest h-index of Therapeutic Advances in Hematology is 32. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Therapeutic Advances in Hematology?

The latest SCImago Journal Rank (SJR) of Therapeutic Advances in Hematology is 1.011. It is calculated in the year 2023.


What is the ranking of Therapeutic Advances in Hematology?

The latest ranking of Therapeutic Advances in Hematology is 4148. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Therapeutic Advances in Hematology?

Therapeutic Advances in Hematology is published by SAGE Publications Inc.. The publication country of this journal is United States.


What is the abbreviation of Therapeutic Advances in Hematology?

This standard abbreviation of Therapeutic Advances in Hematology is .


Is "Therapeutic Advances in Hematology" a Journal, Conference or Book Series?

Therapeutic Advances in Hematology is a journal published by SAGE Publications Inc..


What is the scope of Therapeutic Advances in Hematology?

The scope of Therapeutic Advances in Hematology is as follows:

  • Hematology

For detailed scope of Therapeutic Advances in Hematology, check the official website of this journal.


What is the ISSN of Therapeutic Advances in Hematology?

The International Standard Serial Number (ISSN) of Therapeutic Advances in Hematology is/are as follows: 20406207, 20406215.


What is the best quartile for Therapeutic Advances in Hematology?

The best quartile for Therapeutic Advances in Hematology is Q2.


What is the coverage history of Therapeutic Advances in Hematology?

The coverage history of Therapeutic Advances in Hematology is as follows 2010-2017, 2019-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Business: Theory and Practice Journal Vilnius Gediminas Technical University 13414 21 2.47
Applied Ecology and Environmental Research Journal Corvinus University of Budapest 17545 38 0.74
Journal of International Financial Management and Accounting Journal Wiley-Blackwell Publishing Ltd 6179 42 6.09
Modern Language Journal Journal Wiley-Blackwell 918 103 3.89
Studies in Continuing Education Journal Routledge 6011 38 2.81
Natural Solutions Trade Journal Innovision Health Media 28581 1 0.00
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS Conference And Proceedings Association for Computing Machinery (ACM) 781 100 8.01
Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute Journal Hoikkaido Forest Products Research Institute 25369 4 0.00
Proceedings of the International Semiconductor Conference, CAS Conference And Proceedings Institute of Electrical and Electronics Engineers Inc. 25734 16 0.00
Journal des Professionnels de l'Enfance Journal TPMA 27577 2 0.00

Check complete list




Therapeutic Advances in Hematology Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 2.80
2021 5.55
2020 6.56
2019 0.00
2018 2.67
2016 3.73
2015 3.42
2014 2.55



Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Blood
Elsevier BV | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Leukemia
Nature Publishing Group | United Kingdom

Journal of Thrombosis and Haemostasis
Wiley-Blackwell Publishing Ltd | United Kingdom

Blood advances
Elsevier BV | United States

American Journal of Hematology
Wiley-Liss Inc. | United States

Blood Reviews
Churchill Livingstone | United States

Journal of the National Cancer Center
Chinese National Cancer Center | China

Haematologica
Ferrata Storti Foundation | Italy

Experimental Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Radiotherapy and Oncology
Elsevier Ireland Ltd | Ireland

See All